Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2020; 10(Volume 10, Issue 4.000): 22-27


Fenugreek (Trigonella foenum-graceum) increases postmenopausal fibroblast-associated COL1A1 and COL3A1 production dominantly through its binding to estrogen receptor beta

Shannaz Nadia Yusharyahya, Kusmarinah Bramono, Andon Hestiantoro, Sarah Qanita Edwar, Indra Kusuma.




Abstract
Cited by 6 Articles

In postmenopausal women, oral or topical administration of estradiol increases skin thickness and collagen synthesis, such as collagen type 1 alpha 1 (COL1A1) and collagen type 3 alpha 1 (COL3A1). Due to undesirable side effects of estradiol, such as risks of breast and endometrium pathology, topical phytoestrogens are alternative treatments for aging-related skin changes. Phytoestrogen is a nonsteroidal substance derived from plants, such as fenugreek or Trigonella foenum-graceum L., which has an estrogen like composition that appears to mimic estradiol. The mechanism of action remains unknown, especially in fibroblast-associated COL1A1 and COL3A1 production. In vitro experiments were conducted using postmenopausal women's fibroblasts with estrogen receptor (ER) antagonists. Cell isolation used explant and enzymatic techniques with ELISA kit (MyBioSource, California) for COL1A1 and COL3A1. Paired student t-tests compared results between control (no treatment), fenugreek extract 2 µg/mL alone, fenugreek extract 2 µg/mL with receptor antagonists for ERα, ERβ, and both receptors. Greater suppresion of COL1A1 and COL3A1 were shown by both antagonists ERα / ERβ group and antagonist ERβ group compared to antagonist ERα group. These results indicate that fenugreek increases secretion of COL1A1 and COL3A1 through ERα, ERβ, and is mainly mediated by ERβ in post menopausal women’s fibroblasts.

Key words: COL1A1, COL3A1, Estrogen Receptors, Fenugreek, Human Dermal Fibroblasts






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.